Lorena Rodrigo
Overview
Explore the profile of Lorena Rodrigo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balaguer N, Rodrigo L, Mateu-Brull E, Campos-Galindo I, Castellon J, Al-Asmar N, et al.
BJOG
. 2023 Aug;
131(2):213-221.
PMID: 37533357
Objective: To evaluate cell-free DNA (cfDNA) testing as a non-invasive approach to detecting aneuploidies in clinical miscarriages. Design: A retrospective cohort study of women with pregnancy loss. Setting: Hospitals and...
2.
Ali T, Mateu-Brull E, Balaguer N, Dantas C, Borges H, de Oliveira M, et al.
Eur J Med Res
. 2021 Jun;
26(1):64.
PMID: 34187576
Background: Since 2011, screening maternal blood for cell-free foetal DNA (cffDNA) fragments has offered a robust clinical tool to classify pregnancy as low or high-risk for Down, Edwards, and Patau...
3.
Martin A, Rodrigo L, Beltran D, Meseguer M, Rubio C, Mercader A, et al.
Fertil Steril
. 2021 Mar;
116(1):165-173.
PMID: 33766460
Objective: To provide full morphokinetic characterization of embryos ranked with different degrees of chromosomal mosaicism. Design: Retrospective cohort study. Setting: University-affiliated private in vitro fertilization clinic. Patient(s): We analyzed 1,511...
4.
Boynukalin F, Gultomruk M, Turgut N, Rubio C, Rodrigo L, Yarkiner Z, et al.
J Assist Reprod Genet
. 2021 Jan;
38(2):387-396.
PMID: 33398513
Purpose: To evaluate the factors that affect the incidence of euploid balanced embryos and interchromosomal effect (ICE) in carriers of different structural rearrangements. Methods: This retrospective study includes 95 couples...
5.
Rodrigo L
Best Pract Res Clin Endocrinol Metab
. 2020 Dec;
34(6):101477.
PMID: 33353781
Sperm genetic testing has been proposed for clinical diagnosis of possible causes of male infertility. We reviewed the most remarkable publications of sperm DNA integrity and sperm aneuploidy as they...
6.
Rodrigo L, Clemente-Ciscar M, Campos-Galindo I, Peinado V, Simon C, Rubio C
Genes (Basel)
. 2020 Oct;
11(10).
PMID: 33007801
Highly sensitive next-generation sequencing (NGS) platforms applied to preimplantation genetic testing for aneuploidy (PGT-A) allow the classification of mosaicism in trophectoderm biopsies. However, the incidence of mosaicism reported by these...
7.
Optimized NGS Approach for Detection of Aneuploidies and Mosaicism in PGT-A and Imbalances in PGT-SR
Garcia-Pascual C, Navarro-Sanchez L, Navarro R, Martinez L, Jimenez J, Rodrigo L, et al.
Genes (Basel)
. 2020 Jul;
11(7).
PMID: 32610655
The detection of chromosomal aneuploidies and mosaicism degree in preimplantation embryos may be essential for achieving pregnancy. The aim of this study was to determine the robustness of diagnosing homogenous...
8.
Rodrigo L, Meseguer M, Mateu E, Mercader A, Peinado V, Bori L, et al.
Biol Reprod
. 2019 Jul;
101(6):1091-1101.
PMID: 31318411
In this work we reviewed 18 years of experience using fluorescence in situ hybridization (FISH) for sperm aneuploidy testing. We evaluated parameters associated with increased numerical sperm chromosome abnormalities and...
9.
Rubio C, Rodrigo L, Garcia-Pascual C, Peinado V, Campos-Galindo I, Garcia-Herrero S, et al.
Biol Reprod
. 2019 Feb;
101(6):1083-1090.
PMID: 30721942
We review here the evolution in the field of embryo aneuploidy testing over the last 20 years, from the analysis of a subset of chromosomes by fluorescence in situ hybridisation...
10.
Rubio C, Bellver J, Rodrigo L, Castillon G, Guillen A, Vidal C, et al.
Fertil Steril
. 2017 Apr;
107(5):1122-1129.
PMID: 28433371
Objective: To determine the clinical value of preimplantation genetic diagnosis for aneuploidy screening (PGD-A) in women of advanced maternal age (AMA; between 38 and 41 years). Design: This was a...